USE OF AN ATP BIOLUMINESCENT ASSAY TO EVALUATE VIABILITY OF PNEUMOCYSTIS-CARINII FROM RATS

被引:51
作者
CHEN, F [1 ]
CUSHION, MT [1 ]
机构
[1] UNIV CINCINNATI,COLL MED,DEPT INTERNAL MED,DIV INFECT DIS,CINCINNATI,OH 45267
关键词
D O I
10.1128/JCM.32.11.2791-2800.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A bioluminescent assay which employs the luciferin-luciferase ATP-dependent reaction was used to evaluate the viability of populations of Pneumocystic carinii derived from infected rat lungs. Contamination with host cells was reduced by a purification method which involved a combination of low- and high-speed centrifugations resulting in a 1,000-fold reduction of the rat cells while enriching for the trophic form of P. carinii. A linear correlation for the number of P. carinii nuclei versus the amount of ATP was observed. The ATP content of the organism populations could be maintained at inoculum levels for one week, although the number of organisms did not increase. Addition of respiratory chain inhibitors dramatically decreased the ATP content of the P. carinii after 24 h of incubation, with the exception of the antibiotic oligomycin B. Low concentrations of trimethoprim-sulfamethoxazole and pentamidine isethionate reduced the organism ATP content by over 50% after 24 h of exposure, while no effect was observed with 100-fold greater concentrations of ampicillin. The bioluminescent assay was found to be a more sensitive indicator of viability than a dual fluorescent staining technique. This assay does not require replication of P. carinii and should be a useful method for in vitro drug screening and viability assessment of P. carinii populations.
引用
收藏
页码:2791 / 2800
页数:10
相关论文
共 51 条
  • [1] AHMANN FR, 1987, IN VITRO CELL DEV B, V23, P474
  • [2] PROPAGATION AND PURIFICATION OF RAT PNEUMOCYSTIS-CARINII IN SHORT-TERM CELL-CULTURE
    ARMSTRONG, MYK
    RICHARDS, FF
    [J]. JOURNAL OF PROTOZOOLOGY, 1989, 36 (01): : S24 - S27
  • [3] CULTIVATION OF PNEUMOCYSTIS-CARINII WITH WI-38 CELLS
    BARTLETT, MS
    VERBANAC, PA
    SMITH, JW
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1979, 10 (06) : 796 - 799
  • [4] BAUGHMAN RP, 1994, PNEUMOCYSTIS CARINII, P381
  • [5] CHEN F, IN PRESS EUKARYOT MI
  • [6] MICROCULTURE SCREENING ASSAY FOR PRIMARY INVITRO EVALUATION OF DRUGS AGAINST PNEUMOCYSTIS-CARINII
    COMLEY, JCW
    MULLIN, RJ
    WOLFE, LA
    HANLON, MH
    FERONE, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) : 1965 - 1974
  • [7] CUSHION MT, 1989, J PROTOZOOL, V36, P45
  • [8] EVIDENCE FOR 2 GENETIC-VARIANTS OF PNEUMOCYSTIS-CARINII COINFECTING LABORATORY RATS
    CUSHION, MT
    ZHANG, JX
    KASELIS, M
    GIUNTOLI, D
    STRINGER, SL
    STRINGER, JR
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (05) : 1217 - 1223
  • [9] GENETIC STABILITY AND DIVERSITY OF PNEUMOCYSTIS-CARINII INFECTING RAT COLONIES
    CUSHION, MT
    KASELIS, M
    STRINGER, SL
    STRINGER, JR
    [J]. INFECTION AND IMMUNITY, 1993, 61 (11) : 4801 - 4813
  • [10] METHOD OF TESTING THE SUSCEPTIBILITY OF PNEUMOCYSTIS-CARINII TO ANTIMICROBIAL AGENTS INVITRO
    CUSHION, MT
    STANFORTH, D
    LINKE, MJ
    WALZER, PD
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (06) : 796 - 801